老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cellectar Biosciences, Inc. Series A Warrants

0.1190
0.0000
成交量：- -
成交額：- -
市值：- -
市盈率：- -
高：0.1190
開：0.1190
低：0.1190
收：0.1190
52周最高：0.1900
52周最低：0.0225
股本：- -
流通股本：- -
量比：- -
換手率：- -
股息：- -
股息率：- -
淨資產收益率：--
總資產收益率：--
市淨率：--
市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告
2021/06/04

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/14

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/03

重要事件披露

8-K - Current report
2021/04/30

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/27

重要事件披露

8-K - Current report
2021/04/16

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/03/11

重要事件披露

8-K - Current report
2021/03/09

重要事件披露

8-K - Current report
2021/03/05

重要事件披露

8-K - Current report
2021/03/02

重要事件披露

8-K - Current report
2021/03/02

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
更多